Datavault Ai Inc. has 12 Schedule 13D or 13G filings on record since 2025-08-12. 3 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Scilex Holding Company | 17.2% | 163,766,229 | SCHEDULE 13D/A, 2026-08-24 | 2026-08-20 |
| Nathaniel Bradley | 16.9% | 19,700,790 | SCHEDULE 13D/A, 2025-09-09 | 2025-09-07 |
| Vivasor, Inc. | 5.3% | 50,000,000 | SCHEDULE 13G/A, 2026-08-24 | 2026-06-30 |
| Joseph Reda | 0% | 0 | SCHEDULE 13G/A, 2026-02-13 | 2026-02-13 |
| Gregory Castaldo | 0% | 0 | SCHEDULE 13G, 2026-02-13 | 2026-02-13 |
Purpose of Transaction (Item 4)
Nathaniel Bradley
Item 4 of the Schedule 13D is amended to add the following: 110,909 shares of Common Stock of the Issuer were transferred by EOS Technology Holdings Inc. ("EOS") to a third party in connection with a consulting agreement, dated as of August 19, 2025 (the "Consulting Agreement"), by and between EOS and the consultant under the Consulting Agreement. 10,000,000 shares of Common Stock of the Issuer were issued to EOS pursuant to an amendment and conversion agreement, dated as of September 7, 2025 (the "EOS Note Amendment") between EOS and the Issuer, to the Convertible Promissory Note (the "EOS Note") issued to EOS on December 31, 2024 in the original principal amount of $10,000,000. Pursuant to the EOS Note Amendment, EOS converted (the "EOS Note Conversion") $3,200,000 of the balance of the EOS Note into 10,000,000 shares of Common Stock, at a conversion price of $0.32 per share, and the floor price set forth in the EOS Note was waived and did not apply to the EOS Note Conversion. To the extent required, the disclosure in Item 3 of this Amendment No. 3 is incorporated by reference in this Item 4.Item 4 of the SCHEDULE 13D/A filed 2025-09-09
Scilex Holding Company
Item 4 is hereby amended and supplemented as follows: On August 8, 2026 (the "Effective Date"), Vivasor, Inc. ("Vivasor"), as borrower, issued a Promissory Note (Revolving Line of Credit) (the "Vivasor Note") to the Reporting Person, pursuant to which the Reporting Person established an uncommitted revolving line of credit in favor of Vivasor in a maximum aggregate principal amount of up to $20,000,000 (the "Maximum Credit Amount"). The Vivasor Note has a stated maturity of 120 months from the Effective Date (the "Maturity Date"). The Vivasor Note evidences a revolving line of credit under which Vivasor may, from time to time prior to the Maturity Date, request advances ("Drawdowns") in multiple borrowings, provided that the aggregate outstanding principal balance of all Drawdowns at any time shall not exceed the Maximum Credit Amount. Amounts repaid under the Vivasor Note may be reborrowed, subject to the terms of the Vivasor Note. Notwithstanding the foregoing, the Vivasor Note is uncommitted and the Reporting Person has no obligation to fund any Drawdown; each Drawdown will be funded only if, when and to the extent agreed by the Reporting Person in its sole discretion. Any Drawdown that the Reporting Person agrees to fund may be funded, as determined by the Reporting Person, in (i) cash, (ii) freely tradable securities of the Reporting Person, (iii) shares of Common Stock of the Issuer currently held by the Reporting Person or its subsidiaries, or (iv) any combination …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-24; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | Nathaniel Bradley | 9.9% | SCHEDULE 13D/A |
| 2025-09-09 | Nathaniel Bradley | 16.9% | SCHEDULE 13D/A |
| 2025-10-02 | Scilex Holding Company | 8.03% | SCHEDULE 13D |
| 2025-12-01 | Scilex Holding Company | 47.99% | SCHEDULE 13D |
| 2025-12-31 | Scilex Holding Company | 42.6% | SCHEDULE 13D/A |
| 2026-01-08 | Scilex Holding Company | 40.05% | SCHEDULE 13D/A |
| 2026-01-14 | Scilex Holding Company | 37.27% | SCHEDULE 13D/A |
| 2026-02-13 | Joseph Reda | 0% | SCHEDULE 13G/A |
| 2026-02-13 | Gregory Castaldo | 0% | SCHEDULE 13G |
| 2026-06-02 | Vivasor, Inc. | 6.5% | SCHEDULE 13G |
| 2026-08-24 | Vivasor, Inc. | 5.3% | SCHEDULE 13G/A |
| 2026-08-24 | Scilex Holding Company | 17.2% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Datavault Ai Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.